Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding Study of APD421 for Cisplatin-induced Nausea and Vomiting
NCT01303978Phase 2Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Feb 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of amisulpride in chemotherapy-induced nausea and vomiting (CINV), sponsored by Acacia Pharma Group Plc. Started Feb 2011; status: completed.
02
Drugs
amisulpride
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01303978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303978.